Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Specific recognition of the C-terminal end of A beta 42 by a high affinity monoclonal antibody.

Axelsen TV, Holm A, Birkelund S, Christiansen G, Ploug M, Holm IE.

Mol Immunol. 2009 Jul;46(11-12):2267-73. doi: 10.1016/j.molimm.2009.04.007. Epub 2009 May 17.

PMID:
19447496
2.

Development and characterization of a monoclonal antibody 369.2B specific for the carboxyl-terminus of the beta A4 peptide.

König G, Graham P, Bushnell A, Webster S, Wunderlich D, Perlmutter LS.

Ann N Y Acad Sci. 1996 Jan 17;777:344-55.

PMID:
8624111
3.

Humoral immune response to fibrillar beta-amyloid peptide.

Miller DL, Currie JR, Mehta PD, Potempska A, Hwang YW, Wegiel J.

Biochemistry. 2003 Oct 14;42(40):11682-92.

PMID:
14529278
5.

Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.

Rábano A, Jiménez-Huete A, Acevedo B, Calero M, Ghiso J, Valdés I, Gavilondo J, Frangione B, Méndez E.

Curr Alzheimer Res. 2005 Oct;2(4):409-17.

PMID:
16248846
6.

Human monoclonal antibodies against amyloid-beta from healthy adults.

Geylis V, Kourilov V, Meiner Z, Nennesmo I, Bogdanovic N, Steinitz M.

Neurobiol Aging. 2005 May;26(5):597-606.

PMID:
15708434
7.

A novel monoclonal antibody specific for the amino-truncated beta-amyloid Abeta5-40/42 produced from caspase-cleaved amyloid precursor protein.

Murayama KS, Kametani F, Tabira T, Araki W.

J Neurosci Methods. 2007 Apr 15;161(2):244-9. Epub 2007 Jan 4.

PMID:
17207535
8.
9.

Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.

Wang J, Hara H, Makifuchi T, Tabira T.

J Alzheimers Dis. 2008 Jun;14(2):161-73.

PMID:
18560128
10.

Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.

Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P.

Ann Neurol. 2005 Sep;58(3):430-5.

PMID:
16130106
11.

Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.

Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL.

Protein Eng Des Sel. 2009 Mar;22(3):199-208. doi: 10.1093/protein/gzn052. Epub 2008 Oct 16.

12.

Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.

Moretto N, Bolchi A, Rivetti C, Imbimbo BP, Villetti G, Pietrini V, Polonelli L, Del Signore S, Smith KM, Ferrante RJ, Ottonello S.

J Biol Chem. 2007 Apr 13;282(15):11436-45. Epub 2007 Jan 31.

13.

Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.

Meli G, Visintin M, Cannistraci I, Cattaneo A.

J Mol Biol. 2009 Apr 3;387(3):584-606. doi: 10.1016/j.jmb.2009.01.061. Epub 2009 Feb 4.

PMID:
19361429
15.
16.

Location of an epitope shared by Alzheimer's amyloid peptide and brain creatine kinase using a newly developed monoclonal antibody.

Cazorla P, Aldudo J, Haas C, Vázquez J, Valdivieso F, Bullido MJ.

Biochim Biophys Acta. 1995 Apr 24;1270(2-3):149-56.

17.
18.
19.

Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.

Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F.

Mol Immunol. 2009 Feb;46(4):695-704. doi: 10.1016/j.molimm.2008.09.008. Epub 2008 Oct 18.

PMID:
18930548
20.

Specific reactivity of mild/severe Alzheimer's disease patient's sera to antibody against Abeta1-40 epitope 17-21.

Bolukbasi Hatip FF, Matsunaga Y, Yamada T.

Acta Neurol Scand. 2008 Jun;117(6):404-8. Epub 2007 Nov 13.

PMID:
18005218
Items per page

Supplemental Content

Write to the Help Desk